Vertex Pharmaceuticals Inc. buy UBS Group AG
Start price
07.11.25
/
50%
€352.60
Target price
07.11.26
€473.22
Performance (%)
13.46%
Price
28.01.26
€400.05
Summary
This prediction is currently active. The prediction currently has a performance of 13.46%. This prediction currently runs until 07.11.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Vertex Pharmaceuticals Inc. | 1.343% | 1.343% |
| iShares Core DAX® | 0.170% | 2.184% |
| iShares Nasdaq 100 | 0.515% | 0.370% |
| iShares Nikkei 225® | 1.614% | 6.357% |
| iShares S&P 500 | -0.719% | -0.275% |
Comments by UBS_Group_AG for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (NASDAQ:VRTX) had its price target lowered by analysts at UBS Group AG from $553.00 to $546.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by UBS_Group_AG for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€398.35
26.01.26
26.01.26
-
26.01.27
26.01.27
0.43%
28.01.26
28.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€379.15
09.12.25
09.12.25
-
09.12.26
09.12.26
5.51%
28.01.26
28.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€344.35
05.08.25
05.08.25
€478.40
05.08.26
05.08.26
16.18%
28.01.26
28.01.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.85
05.11.24
05.11.24
€536.01
05.11.25
05.11.25
-21.69%
06.11.25
06.11.25
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€459.95
17.10.24
17.10.24
€519.06
17.10.25
17.10.25
-21.84%
18.10.25
18.10.25